Through its CodeXome platform, Cornerstone Genomics uses cross-species data—especially from primates—to reclassify variants of uncertain significance and accelerate discoveries in diagnostics and drug development.
Through its CodeXome platform, Cornerstone Genomics uses cross-species data—especially from primates—to reclassify variants of uncertain significance and accelerate discoveries in diagnostics and drug development.